Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease

INTRODUCTION: This double-blind, randomized controlled trial compared the safety and efficacy of subcutaneous epoetin alfa-epbx, an epoetin alfa biosimilar, with the reference product, epoetin alfa, in hemodialysis patients with end-stage kidney disease (ESKD) and anemia who were receiving epoetin a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fishbane, Steven, Spinowitz, Bruce S., Wisemandle, Wayne A., Martin, Nancy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734106/
https://www.ncbi.nlm.nih.gov/pubmed/31517143
http://dx.doi.org/10.1016/j.ekir.2019.05.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734106/
https://www.ncbi.nlm.nih.gov/pubmed/31517143
http://dx.doi.org/10.1016/j.ekir.2019.05.010

Ejemplares similares